These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 28706566)

  • 1. Motor vehicle collisions caused by the 'super-strength' synthetic cannabinoids, MAM-2201, 5F-PB-22, 5F-AB-PINACA, 5F-AMB and 5F-ADB in Japan experienced from 2012 to 2014.
    Kaneko S
    Forensic Toxicol; 2017; 35(2):244-251. PubMed ID: 28706566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacology of Indole and Indazole Synthetic Cannabinoid Designer Drugs AB-FUBINACA, ADB-FUBINACA, AB-PINACA, ADB-PINACA, 5F-AB-PINACA, 5F-ADB-PINACA, ADBICA, and 5F-ADBICA.
    Banister SD; Moir M; Stuart J; Kevin RC; Wood KE; Longworth M; Wilkinson SM; Beinat C; Buchanan AS; Glass M; Connor M; McGregor IS; Kassiou M
    ACS Chem Neurosci; 2015 Sep; 6(9):1546-59. PubMed ID: 26134475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabimimetic effects of abused indazole-carboxamide synthetic cannabinoid receptor agonists AB-PINACA, 5F-AB-PINACA and 5F-ADB-PINACA in mice: Tolerance, dependence and withdrawal.
    Wilson CD; Hiranita T; Fantegrossi WE
    Drug Alcohol Depend; 2022 Jul; 236():109468. PubMed ID: 35643039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Convulsant doses of abused synthetic cannabinoid receptor agonists AB-PINACA, 5F-AB-PINACA, 5F-ADB-PINACA and JWH-018 do not elicit electroencephalographic (EEG) seizures in male mice.
    Wilson CD; Zheng F; Fantegrossi WE
    Psychopharmacology (Berl); 2022 Oct; 239(10):3237-3248. PubMed ID: 35933518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of synthetic cannabinoids that were seized, consumed, or associated with deaths in Kuwait in 2018 using GC-MS and LC-MS-MS analysis.
    Al-Matrouk A; Alqallaf M; AlShemmeri A; BoJbarah H
    Forensic Sci Int; 2019 Oct; 303():109960. PubMed ID: 31550599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacology of Valinate and tert-Leucinate Synthetic Cannabinoids 5F-AMBICA, 5F-AMB, 5F-ADB, AMB-FUBINACA, MDMB-FUBINACA, MDMB-CHMICA, and Their Analogues.
    Banister SD; Longworth M; Kevin R; Sachdev S; Santiago M; Stuart J; Mack JB; Glass M; McGregor IS; Connor M; Kassiou M
    ACS Chem Neurosci; 2016 Sep; 7(9):1241-54. PubMed ID: 27421060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection and quantification of 5F-ADB and its methyl ester hydrolysis metabolite in fatal intoxication cases by liquid chromatography-high resolution mass spectrometry.
    Yeter O; Erol Öztürk Y
    Forensic Sci Int; 2019 Sep; 302():109866. PubMed ID: 31302415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enantioseparation of the carboxamide-type synthetic cannabinoids N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide and methyl [1-(5-fluoropentyl)-1H-indazole-3-carbonyl]-valinate in illicit herbal products.
    Doi T; Asada A; Takeda A; Tagami T; Katagi M; Kamata H; Sawabe Y
    J Chromatogr A; 2016 Nov; 1473():83-89. PubMed ID: 27773389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fatal intoxication by 5F-ADB and diphenidine: Detection, quantification, and investigation of their main metabolic pathways in humans by LC/MS/MS and LC/Q-TOFMS.
    Kusano M; Zaitsu K; Taki K; Hisatsune K; Nakajima J; Moriyasu T; Asano T; Hayashi Y; Tsuchihashi H; Ishii A
    Drug Test Anal; 2018 Feb; 10(2):284-293. PubMed ID: 28544560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defining Steric Requirements at CB
    Markham J; Sparkes E; Boyd R; Chen S; Manning JJ; Finlay D; Lai F; McGregor E; Maloney CJ; Gerona RR; Connor M; McGregor IS; Hibbs DE; Glass M; Kevin RC; Banister SD
    ACS Chem Neurosci; 2022 Apr; 13(8):1281-1295. PubMed ID: 35404067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthetic Cannabinoid Hydroxypentyl Metabolites Retain Efficacy at Human Cannabinoid Receptors.
    Gamage TF; Farquhar CE; McKinnie RJ; Kevin RC; McGregor IS; Trudell ML; Wiley JL; Thomas BF
    J Pharmacol Exp Ther; 2019 Mar; 368(3):414-422. PubMed ID: 30552295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5F-MDMB-PICA metabolite identification and cannabinoid receptor activity.
    Truver MT; Watanabe S; Åstrand A; Vikingsson S; Green H; Swortwood MJ; Kronstrand R
    Drug Test Anal; 2020 Jan; 12(1):127-135. PubMed ID: 31461219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The 2-alkyl-2
    Longworth M; Banister SD; Mack JBC; Glass M; Connor M; Kassiou M
    Forensic Toxicol; 2016; 34():286-303. PubMed ID: 27547266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and Pharmacological Profiling of the Metabolites of Synthetic Cannabinoid Drugs APICA, STS-135, ADB-PINACA, and 5F-ADB-PINACA.
    Longworth M; Connor M; Banister SD; Kassiou M
    ACS Chem Neurosci; 2017 Aug; 8(8):1673-1680. PubMed ID: 28574245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic profiling of synthetic cannabinoid 5F-ADB by human liver microsome incubations and urine samples using high-resolution mass spectrometry.
    Yeter O; Ozturk YE
    Drug Test Anal; 2019 Jun; 11(6):847-858. PubMed ID: 30610752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacology of Cumyl-Carboxamide Synthetic Cannabinoid New Psychoactive Substances (NPS) CUMYL-BICA, CUMYL-PICA, CUMYL-5F-PICA, CUMYL-5F-PINACA, and Their Analogues.
    Longworth M; Banister SD; Boyd R; Kevin RC; Connor M; McGregor IS; Kassiou M
    ACS Chem Neurosci; 2017 Oct; 8(10):2159-2167. PubMed ID: 28792725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinguishing Intake of New Synthetic Cannabinoids ADB-PINACA and 5F-ADB-PINACA with Human Hepatocyte Metabolites and High-Resolution Mass Spectrometry.
    Carlier J; Diao X; Scheidweiler KB; Huestis MA
    Clin Chem; 2017 May; 63(5):1008-1021. PubMed ID: 28302730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Schedules of Controlled Substances: Temporary Placement of Six Synthetic Cannabinoids (5F-ADB, 5F-AMB, 5F-APINACA, ADB-FUBINACA, MDMB-CHMICA and MDMB-FUBINACA) into Schedule I. Temporary Scheduling Order.
    Drug Enforcement Administration, Department of Justice
    Fed Regist; 2017 Apr; 82(67):17119-24. PubMed ID: 28425681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic profiling of new synthetic cannabinoids AMB and 5F-AMB by human hepatocyte and liver microsome incubations and high-resolution mass spectrometry.
    Andersson M; Diao X; Wohlfarth A; Scheidweiler KB; Huestis MA
    Rapid Commun Mass Spectrom; 2016 Apr; 30(8):1067-78. PubMed ID: 27003044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enantiospecific Synthesis, Chiral Separation, and Biological Activity of Four Indazole-3-Carboxamide-Type Synthetic Cannabinoid Receptor Agonists and Their Detection in Seized Drug Samples.
    Antonides LH; Cannaert A; Norman C; Vives L; Harrison A; Costello A; Nic Daeid N; Stove CP; Sutcliffe OB; McKenzie C
    Front Chem; 2019; 7():321. PubMed ID: 31157203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.